Seung-Pyo Hong

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Editorial Comment

Top Venues

Experimental & molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hae Rim Jung, Jeonghwan Lee, Seung-Pyo Hong, Nayeon Shin, Ara Cho, Dong-Jin Shin, Jin Woo Choi, Jong-Il Kim, Jung Pyo Lee, Sung-Yup Cho
Targeting the m 6 A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine 56 (2) (2024)
Hae Rim Jung, Jeonghwan Lee, Seung-Pyo Hong, Nayeon Shin, Ara Cho, Dong-Jin Shin, Jin Woo Choi, Jong-Il Kim, Jung Pyo Lee, Sung-Yup Cho
Targeting the m 6 A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine 56 (2) (2024)
Hae Rim Jung, Jeonghwan Lee, Seung-Pyo Hong, Nayeon Shin, Ara Cho, Dong-Jin Shin, Jin Woo Choi, Jong-Il Kim, Jung Pyo Lee, Sung-Yup Cho
Targeting the m 6 A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine (2024)
Hae Rim Jung, Jeonghwan Lee, Seung-Pyo Hong, Nayeon Shin, Ara Cho, Dong-Jin Shin, Jin Woo Choi, Jong-Il Kim, Jung Pyo Lee, Sung-Yup Cho
Targeting the m 6 A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine 56 (2) (2024)
Hae Rim Jung, Jeonghwan Lee, Seung-Pyo Hong, Nayeon Shin, Ara Cho, Dong-Jin Shin, Jin Woo Choi, Jong-Il Kim, Jung Pyo Lee, Sung-Yup Cho
Targeting the m 6 A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine 56 (2) (2024)
Hae Rim Jung, Jeonghwan Lee, Seung-Pyo Hong, Nayeon Shin, Ara Cho, Dong-Jin Shin, Jin Woo Choi, Jong-Il Kim, Jung Pyo Lee, Sung-Yup Cho
Targeting the m 6 A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine 56 (2) (2024)